Article

news

Pfizer and Allergan call off a planned $160 billion merger due to changes in U.S. tax inversion regulations.

ID: 201604071709

zie ook onze nota van 4 november 2014 over 'tax inversion'

zie de infogram van Reuters van 24 november 2015